Serum suPAR in patients with FSGS: trash or treasure? (Q38091638)

28 August 2017

title

Serum suPAR in patients with FSGS: trash or treasure? (English)

1 reference

28 August 2017

Rutger J H Maas

1

1 reference

28 August 2017

Jeroen K J Deegens

series ordinal

2

1 reference

28 August 2017

Jack F M Wetzels

series ordinal

3

1 reference

28 August 2017

publication date

21 March 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

28

1 reference

28 August 2017

issue

7

1 reference

28 August 2017

page(s)

1041-1048

1 reference

Predicting the response to cytotoxic therapy for childhood nephrotic syndrome: superiority of response to corticosteroid therapy over histopathologic patterns.

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Transmission of glomerular permeability factor from a mother to her child

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Urokinase plasminogen activator receptor affects bone homeostasis by regulating osteoblast and osteoclast function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

The urokinase system in the pathogenesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Upregulation of monocyte urokinase plasminogen activator receptor during human endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

The urokinase receptor and integrins in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

uPAR: a versatile signalling orchestrator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Lipid raft compartmentalization of urokinase receptor signaling in human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Regulation of cell signalling by uPAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Integrin inside-out signaling and the immunological synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

uPAR-induced cell adhesion and migration: vitronectin provides the key

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity: generation of a new integrin inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Specific immunofluorimetric assay detecting the chemotactic epitope of the urokinase receptor (uPAR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Modification of kidney barrier function by the urokinase receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

TNFα pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and β3 integrin activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Urokinase receptor (uPAR, CD87) is a platelet receptor important for kinetics and TNF-induced endothelial adhesion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Detection of suPAR in the Saliva of Healthy Young Adults: Comparison with Plasma Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Hyperfibrinolysis, uPA/suPAR system, kynurenines, and the prevalence of cardiovascular disease in patients with chronic renal failure on conservative treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Time-course gait analysis of hemiparkinsonian rats following 6-hydroxydopamine lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

The urokinase plasminogen activator receptor is crucially involved in host defense during acute pyelonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Circulating suPAR in two cohorts of primary FSGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

Furin interacts with proMT1-MMP and integrin alphaV at specialized domains of renal cell plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

High Plasma Levels of Intact and Cleaved Soluble Urokinase Receptor Reflect Immune Activation and Are Independent Predictors of Mortality in HIV-1-Infected Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2452-5

The murine receptor for urokinase-type plasminogen activator is primarily expressed in tissues actively undergoing remodeling

21 January 2018

1 reference

12 December 2020

Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplant

1 reference

12 December 2020

Serum-soluble urokinase receptor concentration in primary FSGS

1 reference

12 December 2020

"The FSGS factor:" enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma

1 reference

12 December 2020

Induction of urokinase receptor expression in nephrotoxic nephritis

1 reference

12 December 2020

The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction

1 reference

12 December 2020

A New Assay for Measurement of the Liberated Domain I of the Urokinase Receptor in Plasma Improves the Prediction of Survival in Colorectal Cancer

1 reference

12 December 2020

Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis

1 reference

12 December 2020

Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation

1 reference

12 December 2020

Review on diagnosis and treatment of focal segmental glomerulosclerosis.

1 reference

12 December 2020

Identification of the urokinase receptor as an adhesion receptor for vitronectin

1 reference

12 December 2020

Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score

1 reference

12 December 2020

Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997

1 reference

12 December 2020

suPAR: the molecular crystal ball

1 reference

12 December 2020

Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome

1 reference

12 December 2020

Vascular endothelial growth factor and uPA/suPAR system in early and advanced chronic kidney disease patients: a new link between angiogenesis and hyperfibrinolysis?

1 reference

12 December 2020

Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis

1 reference

12 December 2020

Podocytes loose their adhesive phenotype in focal segmental glomerulosclerosis

1 reference

12 December 2020

Urokinase receptor forms in serum from non-small cell lung cancer patients: relation to prognosis

1 reference

12 December 2020

Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo

1 reference

12 December 2020

Resolution of recurrent focal segmental glomerulosclerosis after retransplantation

1 reference

12 December 2020

Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis

1 reference

12 December 2020

Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis

1 reference

12 December 2020

Function of the urokinase receptor (CD87) in neutrophil Chemotaxis

1 reference

12 December 2020

The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants

1 reference

12 December 2020

Progression of glomerular diseases: is the podocyte the culprit?

1 reference

12 December 2020

Pretreatment Determination of the Serum Urokinase Plasminogen Activator and its Soluble Receptor in Advanced Small-Cell Lung Cancer or Non-Small-Cell Lung Cancer

1 reference

12 December 2020

Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol

1 reference

12 December 2020

Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in systemic lupus erythematosus

1 reference

12 December 2020

10.1007/S00467-013-2452-5

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1006085225

0 references

1 reference